1. Home
  2. ADAG vs COLA Comparison

ADAG vs COLA Comparison

Compare ADAG & COLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • COLA
  • Stock Information
  • Founded
  • ADAG 2011
  • COLA 2024
  • Country
  • ADAG China
  • COLA Singapore
  • Employees
  • ADAG N/A
  • COLA N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • COLA
  • Sector
  • ADAG Health Care
  • COLA
  • Exchange
  • ADAG Nasdaq
  • COLA NYSE
  • Market Cap
  • ADAG 76.3M
  • COLA 79.8M
  • IPO Year
  • ADAG 2021
  • COLA 2025
  • Fundamental
  • Price
  • ADAG $1.90
  • COLA $10.10
  • Analyst Decision
  • ADAG Strong Buy
  • COLA
  • Analyst Count
  • ADAG 1
  • COLA 0
  • Target Price
  • ADAG $8.00
  • COLA N/A
  • AVG Volume (30 Days)
  • ADAG 75.3K
  • COLA 13.6K
  • Earning Date
  • ADAG 07-24-2025
  • COLA 01-01-0001
  • Dividend Yield
  • ADAG N/A
  • COLA N/A
  • EPS Growth
  • ADAG N/A
  • COLA N/A
  • EPS
  • ADAG N/A
  • COLA N/A
  • Revenue
  • ADAG $103,204.00
  • COLA N/A
  • Revenue This Year
  • ADAG $6,488.89
  • COLA N/A
  • Revenue Next Year
  • ADAG $57.50
  • COLA N/A
  • P/E Ratio
  • ADAG N/A
  • COLA N/A
  • Revenue Growth
  • ADAG N/A
  • COLA N/A
  • 52 Week Low
  • ADAG $1.33
  • COLA $9.95
  • 52 Week High
  • ADAG $3.58
  • COLA $10.12
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 52.47
  • COLA N/A
  • Support Level
  • ADAG $1.73
  • COLA N/A
  • Resistance Level
  • ADAG $2.02
  • COLA N/A
  • Average True Range (ATR)
  • ADAG 0.15
  • COLA 0.00
  • MACD
  • ADAG -0.01
  • COLA 0.00
  • Stochastic Oscillator
  • ADAG 42.50
  • COLA 0.00

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

About COLA COLUMBUS ACQUISITION CORP

Columbus Acquisition Corp is a blank check company.

Share on Social Networks: